VACV has a broad host-range in vivo and in cell lines, capable of entering nearly all cell 57 types examined to date and initiating the synthesis of the early set of viral proteins (11). 58
However, whether viral replication proceeds to completion or not depends on the host 59 cell type and often requires virus-encoded host-range genes, including K1L and C7L (11). 60 VACV requires either K1L or C7L for productive replication in most mammalian cells (3, 61 17), but it requires neither for replication in avian cells and in a few specific mammalian 62 cell lines such as human hepatoma Huh7 cells (13). When Huh7 cells are pretreated with 63 type I interferon (IFN), however, K1L or C7L is required for replication beyond early 64 gene expression (13), suggesting that K1L and C7L support VACV replication by 65 antagonizing some antiviral factors that are constitutively expressed in most mammalian 66 cells but are only induced by IFN in some cell lines such as Huh7 (13). 67 K1L and C7L function equivalently at supporting VACV replication in most 68 mammalian cells, but they share no sequence similarity. K1 protein has 284 amino acids 69 and comprises entirely of ankyrin repeats (8), a protein motif that is involved in protein-70 ligand interaction (19). In contrast, C7 protein has 150 amino acids and no discernable 
C7L
-through homologous 101 recombination with specific transfer plasmids, as described previously (12) (Fig. 1A) . 
-but permitted the replication of vVACV-C7L. 216
Also similar to 3T3, LA-4 allowed the replication of vSWPV-064 but restricted the 217 replication of vSPPV-063 ( Fig. 2A) , suggesting that the defect of SPPV-063 is specific to 218 murine cells. 219
In the nonpermissive murine cells, vSPPV-063 did not express green fluorescence 220 protein (GFP) that was controlled by the late P11 promoter (data not shown), suggesting 221 that its replication was blocked before late protein synthesis. Indeed, WR148, a late 222 protein of VACV, was not detected in LA-4 cells that had been infected with vSPPV-063 223 for 8 hours, while it was expressed in cells that had been infected with either vVACV-224 C7L or vSWPV-064 (Fig. 2B ). Furthermore, a reduced amount of D12, an early protein, 225
and SPPV-063, were detected in vSPPV-063-infected LA-4 cells, indicating that early 226 protein synthesis was also reduced. This is consistent with recent reports that VACV 227 lacking K1L and C7L failed to maintain the synthesis of early proteins such as E3 in 228 nonpermissive cells (2, 12, 21). 229
Mapping SPPV 063 residues that are responsible for its specific defect in murine 231
cells. 232
SPPV 063 is unique among all C7L homologues in that it shows a specific defect 233 in murine cells. This is probably due to some subtle difference between SPPV 063 and 234 other C7L homologues in residues that interact with the putative host restriction factor. 235
The human and murine version of the host restriction factor, in turn, may have some 236 subtle difference in residues that interact with the C7 family of viral proteins. Thus, in an 237 effort to gain some insight into the host factor-interacting site in C7 family of viral 238 proteins, we went on to map SPPV 063 residues that are responsible for its specific defect 239 in murine cells. We took the approach of creating chimeras between SPPV 063 and 240 SWPV 064, the latter of which is the closest homologue of SPPV 063 (47% amino acid 241 identity) but is functional in both human and murine cells. 242 SPPV 063 was initially divided into three segments, each of which was 243 individually substituted with the corresponding region of SWPV 064 (Fig. 3A) . 244
Recombinant viruses expressing the chimeras were constructed with vK1L -
C7L
-as the 245 parental virus on VERO cells, and replication capabilities of the viruses were assessed 246 with HeLa and 3T3 cells ( Fig. 3B and 3C ). The substitution of C-terminal one third of 247 SPPV 063 was sufficient to make it functional in both human and murine cells, as the 248 viruses expressing chimeras containing either C-terminal one third or two thirds of SPPV 249 063 were able to replicate in both HeLa and 3T3 cells (115-185 and 56-185 in Fig. 3) . In 250 contrast, the substitution of central one third of SPPV 063 did not alter its functionality in 251 human or murine cells (56-113 in Fig. 3 ), while the substitution of N-terminal one third 252 or two thirds of SPPV 063 disrupted its function in both human and murine cells (1-55 253 and 1-113 in Fig. 3 ). Since the latter two substitutions resulted in proteins that were 254 defective in both human and murine cells, we then assessed whether the substitutions 255 might affect protein folding and consequently make the protein unstable, by comparing 256 the levels of the chimera proteins in VERO cells. In contrast to HeLa and 3T3 cells, 257 VERO cells were permissive for all the mutants. As a result, there was no difference in 258 replication capacities of the mutants in VERO cells that would have affected overall early 259 protein expression levels. Therefore any differences in chimera protein levels would 260 reflect a difference in the stability of the proteins. A similar level of viral early protein 261 D12 was detected in VERO cells infected by all the mutants, but a reduced level of the 262 chimera protein was detected in VERO cells infected by viruses encoding SPPV 063 with 263 substitution at 1-55 or 1-113 (Fig. 3B) , suggesting that these two substitutions affected 264 protein folding and made the protein unstable. 265
Since substitution of the C-terminal one third (residue 115-185) of SPPV 063 was 266 sufficient to make it functional in both human and murine cells, we then further divided 267 this section of SPPV 063 into two segments for substitutions. The substitution of residues 268 115-153 was sufficient to make the protein functional in both human and murine cells, 269 while the substitution of 154-185 did not alter the functionality of the protein (Fig. 3) . 270
Further dividing residue 115-153 into three segments for substitution revealed that the 271 substitution of eight amino acids (from 129-136) was sufficient to make the protein 272 functional as a host-range factor in both human and murine cells. Among the eight amino 273 acids, only four are different between SPPV 063 and SWPV 064. Substituting Asn134 274 and Phe135 together was sufficient to make the protein functional in human and murine 275 cells, while substituting either Arg129 or Cys132 had no effect on the function of the 276
protein. 277
Altogether, the data showed that residues 134 and 135 were largely responsible 278 for the specific defect of SPPV 063 in murine cells, suggesting that these two residues are 279 critical for the function of the C7 family of host-range proteins. VACV C7 has identical 280 residues (Tyr135 and Ile136) to that of SWPV 064 at positions corresponding to 134-135 281 of SPPV 063. To assess whether these two residues are also critical for the function of C7, 282
we generated a mutant of vVACV-C7L in which these two residues were substituted with 283 alanines. The mutant replicated productively in VERO cells, but it failed to replicate in 284
HeLa or 3T3 cells (supplemental fig. 1 
C7L
-by more than 10-fold while only 297 slightly reducing the yield of VACV-C7L (Fig. 4) . Similar to vK1L reduced by more than 10-fold with IFN-β pre-treatment (Fig. 4) 
-before the late protein synthesis, as indicated by 2-3 log reduction in intensity of 309 GFP, which was expressed by the virus under the P11 late promoter (Fig. 4) . ISGs was similar or better than replication in control cells expressing Fluc (Fig. 5A and  339 Supplemental (Fig. 5B) . Select ISGs that targeted either 342 virus or showed differential inhibition between the two viruses were re-screened by 343 measuring the inhibition from four replicates using fresh lentiviral stocks (Fig. 5C) . 344
Interferon-regulated factor 1 (IRF1) was the only ISG that was confirmed to significantly 345 inhibit the replication of vK1L (Fig. 6D,E) , demonstrating the specificity of IRF1. 373
To determine whether IRF1 inhibition could be the mechanism by which C7L 374 family supports viral replication, we tested whether a functional C7L was required for 375 
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